Clinical Trials Logo

Clinical Trial Summary

The investigators,according to the eligibility criteria,plane to choose 80 elderly anticipates who will undergo selective hip replacement surgery.This participants will be randomly divided into 2 groups:light anesthesia depth group(L Group) and deep anesthesia depth group (D Group).Before anesthesia induction,each participant will be given lumbar plexus and sciatic nerve block in order to control pain of interoperative and postoperative.During operation period,the L Group will be kept in light anesthesia depth(BIS:50-60),while the D group will be kept in deep anesthesia depth(BIS:35-45)--The BIS values in the range of 30-60 have been recommended in general anesthesia.After operation,a PCIA(patient controlled intravenous analgesia) analgesia pump will be given to each participant to control postoperative pain. The investigator will evaluate the mental state of participant with MMSE(mini-mental state examination) before surgery and review each participant with a CAM-CR for 3 days after surgery to assess the situation of postoperation delirium.intraoperative awareness,postoperative pain will also be investigated in postoperative days 1, 2, 3.


Clinical Trial Description

The investigators,according to the eligibility criteria,plane to choose 80 elderly participants who will undergo selective hip replacement surgery.This participants will be randomly divided into 2 groups:light anesthesia depth group(BIS:50-60) and deep anesthesia depth group (BIS:35-45)--The BIS values in the range of 30-60 have been recommended in general anesthesia.Before anesthesia induction,each participant will be given lumbar plexus and sciatic nerve block in order to control pain of intraoperative and postoperative.The investigator use propofol 4ug\kg、and sufentanil 0.2ug\kg during anesthesia induction period,after that,a Laryngeal mask will be placed into patient's mouth.Anesthesia is maintained with remifentanil TCI(target-controlled infusion) target-controlled infusion(concentration:2ng/ml) and propofol BIS closed-loop target-controlled infusion.During the operation period ,the investigator keep the L Group`s BIS range from 50 to 60.While the D Group`s BIS range from 35 to 45.All participants receive postoperative analgesia.After operation,all participants will be send to PACU(post-anaesthesia care unit ) to wake up and send back to ward,And a PCIA(patient controlled intravenous analgesia) analgesia pump will be given to each participants to control postoperative pain.The investigators will use MMSE(mini-mental state examination) to evaluate the participant's mental state before surgery.For 3 days after operation,The investigator will review each participant with a CAM-CR to assess the situation of postoperation delirium.The investigator will see if there is intraoperative awareness by asking questions.Postoperative pain(with VAS) will also be investigated in postoperative days 1, 2, 3. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02972762
Study type Interventional
Source Xiangya Hospital of Central South University
Contact
Status Enrolling by invitation
Phase Early Phase 1
Start date November 2016
Completion date December 2018

See also
  Status Clinical Trial Phase
Completed NCT02062437 - Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair N/A
Completed NCT00393848 - Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery Phase 2
Completed NCT01496300 - Benefit of Orthopedic Navigation in the ARThroplasty of the Hip Phase 4
Completed NCT00244400 - Examine the Possible Association of Hepatic CYP3A Activity and the Susceptibility to Femur Head Necrosis N/A
Recruiting NCT02230826 - Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
Completed NCT02062450 - Observational Study Evaluating Outcomes of Hip Arthroplasty Using Tornier Dual Mobility Acetabular Cup N/A
Not yet recruiting NCT06410079 - Difference in Return to Sports Activity After Hip Arthroplasty by THR or Resurfacing
Active, not recruiting NCT02288117 - Prospective Clinical 5-year Follow-up of the LINK® SP-CL® Hip Prosthesis Stem
Completed NCT02379663 - Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty Phase 4
Enrolling by invitation NCT02365077 - GWAS Identified Susceptibility Loci for Glucocorticoid-induced FHN in the Chinese Population
Completed NCT02733900 - Modifications of the Subchondral Bone in Aseptic Osteonecrosis of the Femoral Head N/A
Not yet recruiting NCT02633904 - Investigation of the Femoral Shortening Osteotomy in the Developmental Dislocation of the Hip (FSODDH) N/A
Withdrawn NCT02799654 - Excia T Cementless EBRA Study N/A